Sodium Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sodium Acetate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/03/2016. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-3299-06
- Dosage Form
- Injection
- Presentation
- Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)
- Initial Posting
- 02/03/2016
- Revised Date
Reason
Other